USD
$0.00
(0.00%
)At Close (As of Sep 26, 2025)
$170.53M
Market Cap
-
P/E Ratio
-0.06
EPS
$9.50
52 Week High
$0.61
52 Week Low
HEALTHCARE
Sector
Field | Value (SGD) |
---|---|
Total Assets | $1.7M |
Total Current Assets | $1.7M |
Cash And Cash Equivalents At Carrying Value | $116K |
Cash And Short Term Investments | $116K |
Inventory | $1.7K |
Current Net Receivables | $119K |
Total Non Current Assets | $89K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $0 |
Short Term Investments | - |
Other Current Assets | $1.4M |
Other Non Current Assets | - |
Total Liabilities | $6.2M |
Total Current Liabilities | $6M |
Current Accounts Payable | - |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $91K |
Total Non Current Liabilities | $164K |
Capital Lease Obligations | $36K |
Long Term Debt | $164K |
Current Long Term Debt | $55K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $255K |
Other Current Liabilities | $5.9M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$4.5M |
Treasury Stock | - |
Retained Earnings | -$4.6M |
Common Stock | $24K |
Common Stock Shares Outstanding | $22M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Cuprina Holdings (Cayman) Limited specializes in innovative biomedical solutions, primarily targeting the development and commercialization of advanced products for chronic wound management. With a firm commitment to enhancing healthcare outcomes, the company leverages cutting-edge biotechnology to address the significant unmet needs in wound care. As it advances its product pipeline, Cuprina is positioned to make a substantial impact in a growing market, offering solutions that aim to improve patient quality of life and reduce healthcare costs associated with chronic wound treatment.